Double Blind, Placebo Controlled Evaluation of a Novel Skin Lightening Agent

January 2018 | Volume 17 | Issue 1 | Original Article | 113 | Copyright © January 2018


James M. Spencer MD MS,a Julianna Accioly MA,a Neal Kitchen PhDb

aSpencer Dermatology & Skin Surgery Center, St Petersburg, FL bHydroPeptide, Issaquah, WA

REFERENCES

  1. Li JY, Geddes ERC, Robinson DM, et al. A review of melasma treatment focusing on laser and light devices. Sem Cutan Med Surg 2016;35:223-232.
  2. Sofen B, Prado G, Emer J. Melasma and post inflammatory hyperpigmentation: management update and expert opinion. Skin Ther Letter, http://www. skintherapy letter.com/2016/21.1/1.htlm, accessed 4/10/17.

AUTHOR CORRESPONDENCE

James M. Spencer MD MS jgspencer@tampabay.rr.com